Contrast Media Reduction and Removal in Patients With Chronic Kidney Disease (CKD) (PRESERV)

NATerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

November 30, 2013

Conditions
Radiographic Contrast Agent Nephropathy
Interventions
DEVICE

CINCOR™ System and contrast conservation unit (CCS-1)

Catheter based system to reduce and remove contrast media and contrast modulator to reduce contrast media

OTHER

Standard of Care plus peri-procedural hydration

The control group will receive a peri and post-procedural hydration rate.

Trial Locations (21)

17405

York Hospital, York

23507

Sentara Norfolk General Hospital, Norfolk

25304

Charleston Area Medical Center, Charleston

29204

South Carolina Heart Center, Columbia

29605

Greenville Health System, Greenville

30342

Saint Joseph's Hospital of Atlanta, Atlanta

33021

Infinity Clinical Research, Hollywood

33753

The Heart and Vascular Institute of Florida, Clearwater

35801

Heart Care Research, LLC, Huntsville

37934

Tennova Healthcare - Turkey Creek Medical Center, Knoxville

44035

Elyria Memorial Hospital Medical Center, Elyria

46237

Franciscan St. Francis Health, Indianapolis

55805

St. Mary's Medical Center, Duluth

73120

Oklahoma Foundation for Cardiovascular Research, Oklahoma City

75701

Cardiovascular Associates of East Texas, PA, Tyler

77030

The Methodist Hospital of Research, Houston

85006

St. Luke's Medical Center, Phoenix

90027

Kaiser Permanente, Los Angeles

90502

Harbor UCLA, Torrance

94305

Stanford Hospitals and Clinics, Stanford

04289

Cardiology Center Leipzig Ltd., Leipzig

Sponsors
All Listed Sponsors
lead

Osprey Medical, Inc

INDUSTRY